Annual FCF
-$30.55 M
+$37.30 M+54.98%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual free cash flow is currently -$30.55 million, with the most recent change of +$37.30 million (+54.98%) on 31 December 2023. ZBIO annual FCF is now at all-time high.ZBIO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$31.06 M
-$65.00 K-0.21%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly free cash flow is currently -$31.06 million, with the most recent change of -$65.00 thousand (-0.21%) on 30 September 2024. Over the past year, it has dropped by -$15.64 million (-101.46%). ZBIO quarterly FCF is now -197.53% below its all-time high of $31.85 million, reached on 30 September 2023.ZBIO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$96.59 M
-$62.91 M-186.72%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology TTM free cash flow is currently -$96.59 million, with the most recent change of -$62.91 million (-186.72%) on 30 September 2024. Over the past year, it has dropped by -$113.02 million (-687.95%). ZBIO TTM FCF is now -403.32% below its all-time high of $31.85 million, reached on 30 September 2023.ZBIO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -101.5% | -688.0% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ZBIO Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +55.0% | -197.5% | at low | -403.3% | at low |
| 5 y | 5 years | at high | +55.0% | -197.5% | at low | -403.3% | at low |
| alltime | all time | at high | +55.0% | -197.5% | at low | -403.3% | at low |
ProShares UltraPro Short Nasdaq Biotechnology Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$31.06 M(+0.2%) | -$96.59 M(+186.7%) |
| June 2024 | - | -$30.99 M(+62.1%) | -$33.69 M(+1150.1%) |
| Mar 2024 | - | -$19.12 M(+24.0%) | -$2.69 M(-116.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$30.55 M(-55.0%) | -$15.42 M(-148.4%) | $16.43 M(-48.4%) |
| Sept 2023 | - | $31.85 M | $31.85 M |
| Dec 2022 | -$67.85 M | - | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual free cash flow?
- What is the all time high annual FCF for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly free cash flow?
- What is the all time high quarterly FCF for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly FCF year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology TTM free cash flow?
- What is the all time high TTM FCF for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology TTM FCF year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual free cash flow?
The current annual FCF of ZBIO is -$30.55 M
What is the all time high annual FCF for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual free cash flow is -$30.55 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly free cash flow?
The current quarterly FCF of ZBIO is -$31.06 M
What is the all time high quarterly FCF for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly free cash flow is $31.85 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly FCF year-on-year change?
Over the past year, ZBIO quarterly free cash flow has changed by -$15.64 M (-101.46%)
What is ProShares UltraPro Short Nasdaq Biotechnology TTM free cash flow?
The current TTM FCF of ZBIO is -$96.59 M
What is the all time high TTM FCF for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high TTM free cash flow is $31.85 M
What is ProShares UltraPro Short Nasdaq Biotechnology TTM FCF year-on-year change?
Over the past year, ZBIO TTM free cash flow has changed by -$113.02 M (-687.95%)